Cross-species comparison of drug handling with near-physiological kidney transporter model - News-Medical.Net
跨物種比較藥物處理的近生理腎臟運輸蛋白模型

Clinicopathologic Study of 28 Cases of Tubulocystic Renal Cell Carcinoma: Is It Time to Reclassify It as a Tubulocystic Renal Cell Tumor? - Cureus
28例管囊腎細胞癌的臨床病理研究：是時候將其重新分類為管囊腎細胞腫瘤了嗎？

BMI OrganBank Secures $3.5 Million NIH Grant to Advance Innovative Kidney Preservation Technology Towards Clinical Trials - PR Newswire
BMI OrganBank 獲得 350 萬美元的 NIH 補助金，以推進創新的腎臟保存技術，邁向臨床試驗。

Dallas Nephrology Associates is Pioneering Value-Based Care, Transforming Kidney Disease Management - Business Wire
達拉斯腎臟科醫療團隊正在開創以價值為基礎的醫療，改變腎病管理。

Kidney Disease Leader Travere Therapeutics Pulls Back To Key Level - Yahoo! Voices
腎病領導者 Travere Therapeutics 回落至關鍵水平

Kidney Disease Leader Travere Therapeutics Pulls Back To Key Level - Investor's Business Daily
腎病領導者 Travere Therapeutics 回落至關鍵水平

Study links phosphate levels to kidney damage markers - Medical Xpress
研究將磷酸鹽水平與腎臟損傷指標聯繫起來

Discover Your Heart Health: Care Access Hosts No-Cost Heart & Kidney Health Screenings in Van Nuys - Business Wire
發現你的心臟健康：Care Access 在 Van Nuys 舉辦免費的心臟和腎臟健康篩檢活動

A Retrospective Analysis of Mortality Due to Pneumonia and Renal Disease in a Midwestern Patient Population - Cureus
中西部病患群體中因肺炎和腎病造成的死亡率回顧性分析

Tissue factor pathway inhibitor 2 (TFPI2) is a potential serum biomarker for clear cell renal carcinoma - Nature.com
組織因子通路抑制劑 2 (TFPI2) 是透明細胞腎癌的一個潛在血清生物標記。